William Blair Investment Management LLC Has $27.07 Million Position in Maximus, Inc. $MMS

William Blair Investment Management LLC reduced its position in shares of Maximus, Inc. (NYSE:MMS) by 9.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 313,594 shares of the health services provider’s stock after selling 31,716 shares during the period. William Blair Investment Management LLC owned about 0.57% of Maximus worth $27,069,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of MMS. Farther Finance Advisors LLC boosted its position in Maximus by 69.0% during the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after purchasing an additional 116 shares during the last quarter. Advisory Services Network LLC acquired a new position in Maximus during the third quarter valued at approximately $32,000. Canada Pension Plan Investment Board acquired a new position in Maximus during the second quarter valued at approximately $35,000. Cullen Frost Bankers Inc. acquired a new position in Maximus during the third quarter valued at approximately $38,000. Finally, Richardson Financial Services Inc. boosted its position in Maximus by 29.6% during the fourth quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after purchasing an additional 103 shares during the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Price Performance

NYSE:MMS opened at $61.09 on Tuesday. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87. The stock’s 50 day moving average price is $65.26 and its two-hundred day moving average price is $77.89. The firm has a market capitalization of $3.21 billion, a price-to-earnings ratio of 9.15 and a beta of 0.60. Maximus, Inc. has a 12-month low of $56.92 and a 12-month high of $100.00.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.98 by $0.09. The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The business’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, analysts anticipate that Maximus, Inc. will post 8.4 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be paid a $0.33 dividend. The ex-dividend date is Friday, May 15th. This represents a $1.32 annualized dividend and a yield of 2.2%. Maximus’s dividend payout ratio is currently 19.76%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on MMS shares. Zacks Research cut Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Finally, Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of “Hold”.

Insider Transactions at Maximus

In other Maximus news, Director Jan Madsen sold 742 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the sale, the director owned 20,795 shares in the company, valued at $1,502,438.75. This represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.80% of the stock is owned by corporate insiders.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.